Title of Collaborative Activity: |
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC) |
Description of Collaborative Activity: |
The Bespoke Gene Therapy Consortium (BGTC) is a developing public-private partnership dedicated to making gene therapy a reality for people with rare genetic diseases affecting populations too small to be viable from the current commercial perspective. |
Type of Collaborative Activity: |
Research Initiative
|
Year the Collaborative Activity Originated: |
2019 |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NHLBI, NIMH, NINDS |
HHS Agency Collaborators on this Activity: |
FDA |
